Eculizumab biosimilar (Turgut Ardika)
依库珠单抗生物类似药（Turgut Ardika）
Report date: 2023/05/19 20:00:21
Base Information
Drug NameEculizumab biosimilar (Turgut Ardika)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTurgut Ardika Pty Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTurgut Ardika Pty Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A